RADHA BERNANDER: Open Payments
NPI 1396273595 · KATY, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$33,447 in 198 payments from 32 companies in 2025. Trend: 2023 $3,877 · 2024 $30,621 · 2025 $33,447
Speaker / faculty: $29,959Food & beverage: $3,488
| Company | Payments | Amount |
|---|---|---|
| Insulet Corporation | 44 | $30,017 |
| Mannkind Corporation | 14 | $439 |
| Lilly USA, LLC | 15 | $342 |
| Corcept Therapeutics | 15 | $296 |
| Tandem Diabetes Care, Inc. | 6 | $256 |
| Novo Nordisk Inc | 14 | $206 |
| CeQur Corporation | 1 | $200 |
| Amgen Inc. | 12 | $193 |
| Ascendis Pharma Endocrinology Inc | 3 | $173 |
| Dexcom, Inc. | 20 | $159 |
Products named: OMNIPOD, AFREZZA, Korlym, t:slim X2 Insulin Pump with Control-IQ, MOUNJARO, CeQur Simplicity, Yorvipath, Dexcom G6 Transmitter.
Industry payments across TX — which companies pay providers there.
